BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 23097128)

  • 1. Effects of hypertrophy and fibrosis on regional and global functional heterogeneity in hypertrophic cardiomyopathy.
    Chang SA; Lee SC; Choe YH; Hahn HJ; Jang SY; Park SJ; Choi JO; Park SW; Oh JK
    Int J Cardiovasc Imaging; 2012 Dec; 28 Suppl 2():133-40. PubMed ID: 23097128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy.
    Urbano-Moral JA; Rowin EJ; Maron MS; Crean A; Pandian NG
    Circ Cardiovasc Imaging; 2014 Jan; 7(1):11-9. PubMed ID: 24275954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systolic and diastolic myocardial mechanics in hypertrophic cardiomyopathy and their link to the extent of hypertrophy, replacement fibrosis and interstitial fibrosis.
    Nucifora G; Muser D; Gianfagna P; Morocutti G; Proclemer A
    Int J Cardiovasc Imaging; 2015 Dec; 31(8):1603-10. PubMed ID: 26210792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction.
    Ellims AH; Iles LM; Ling LH; Hare JL; Kaye DM; Taylor AJ
    J Cardiovasc Magn Reson; 2012 Oct; 14(1):76. PubMed ID: 23107451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left atrial fibrosis correlates with extent of left ventricular myocardial delayed enhancement and left ventricular strain in hypertrophic cardiomyopathy.
    Latif SR; Nguyen VQ; Peters DC; Soufer A; Henry ML; Grunseich K; Testani J; Hur DJ; Huber S; Mojibian H; Dicks D; Sinusas AJ; Meadows JL; Papoutsidakis N; Jacoby D; Baldassarre LA
    Int J Cardiovasc Imaging; 2019 Jul; 35(7):1309-1318. PubMed ID: 30790116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In patients with hypertrophic cardiomyopathy myocardial fibrosis is associated with both left ventricular and left atrial dysfunction.
    Prinz C; Van Buuren F; Bogunovic N; Bitter T; Faber L; Horstkotte D
    Acta Cardiol; 2012 Apr; 67(2):187-93. PubMed ID: 22641976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degree and distribution of left ventricular hypertrophy as a determining factor for elevated natriuretic peptide levels in patients with hypertrophic cardiomyopathy: insights from cardiac magnetic resonance imaging.
    Park JR; Choi JO; Han HJ; Chang SA; Park SJ; Lee SC; Choe YH; Park SW; Oh JK
    Int J Cardiovasc Imaging; 2012 Apr; 28(4):763-72. PubMed ID: 21516440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in Fabry cardiomyopathy between female and male patients: consequences for diagnostic assessment.
    Niemann M; Herrmann S; Hu K; Breunig F; Strotmann J; Beer M; Machann W; Voelker W; Ertl G; Wanner C; Weidemann F
    JACC Cardiovasc Imaging; 2011 Jun; 4(6):592-601. PubMed ID: 21679893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early segmental relaxation abnormalities in hypertrophic cardiomyopathy for differential diagnostic of patients with left ventricular hypertrophy.
    Voigt C; Münch J; Avanesov M; Suling A; Witzel K; Lund G; Patten M
    Clin Cardiol; 2017 Nov; 40(11):1026-1032. PubMed ID: 28741295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular function in patients with hypertrophic cardiomyopathy and its relation to myocardial fibrosis and exercise tolerance.
    Maragiannis D; Alvarez PA; Ghosn MG; Chin K; Hinojosa JJ; Buergler JM; Shah DJ; Nagueh SF
    Int J Cardiovasc Imaging; 2018 Jan; 34(1):121-129. PubMed ID: 28748418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early marker of regional left ventricular deformation in patients with hypertrophic cardiomyopathy evaluated by MRI tissue tracking: The effects of myocardial hypertrophy and fibrosis.
    Xu HY; Chen J; Yang ZG; Li R; Shi K; Zhang Q; Liu X; Xie LJ; Jiang L; Guo YK
    J Magn Reson Imaging; 2017 Nov; 46(5):1368-1376. PubMed ID: 28370909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular structure and diastolic function by cardiac magnetic resonance imaging in hypertrophic cardiomyopathy.
    Chacko BR; Karur GR; Connelly KA; Yan RT; Kirpalani A; Wald R; Jimenez-Juan L; Jacob JR; Deva DP; Yan AT
    Indian Heart J; 2018; 70(1):75-81. PubMed ID: 29455792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endomyocardial radial strain imaging and left ventricular relaxation abnormalities in patients with hypertrophic cardiomyopathy or hypertensive left ventricular hypertrophy.
    Minoshima M; Noda A; Nishizawa T; Hara Y; Sugiura M; Iino S; Nagata K; Koike Y; Murohara T
    Circ J; 2009 Dec; 73(12):2294-9. PubMed ID: 19838000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of basal-septal fibrosis with LV outflow tract obstruction in hypertrophic cardiomyopathy: insights from cardiac magnetic resonance analysis.
    Nakamura T; Iwanaga Y; Yasuda M; Kawamura T; Miyaji Y; Morooka H; Miyazaki S
    Int J Cardiovasc Imaging; 2016 Apr; 32(4):613-20. PubMed ID: 26589516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular wall thickness and regional systolic function in patients with hypertrophic cardiomyopathy. A three-dimensional tagged magnetic resonance imaging study.
    Dong SJ; MacGregor JH; Crawley AP; McVeigh E; Belenkie I; Smith ER; Tyberg JV; Beyar R
    Circulation; 1994 Sep; 90(3):1200-9. PubMed ID: 8087929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study.
    Hinojar R; Varma N; Child N; Goodman B; Jabbour A; Yu CY; Gebker R; Doltra A; Kelle S; Khan S; Rogers T; Arroyo Ucar E; Cummins C; Carr-White G; Nagel E; Puntmann VO
    Circ Cardiovasc Imaging; 2015 Dec; 8(12):. PubMed ID: 26659373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertrophic cardiomyopathy: preclinical and early phenotype.
    Ho CY
    J Cardiovasc Transl Res; 2009 Dec; 2(4):462-70. PubMed ID: 20560004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Right ventricular myocardial involvement in either physiological or pathological left ventricular hypertrophy: an ultrasound speckle-tracking two-dimensional strain analysis.
    D'Andrea A; Caso P; Bossone E; Scarafile R; Riegler L; Di Salvo G; Gravino R; Cocchia R; Castaldo F; Salerno G; Golia E; Limongelli G; De Corato G; Cuomo S; Pacileo G; Russo MG; Calabrò R
    Eur J Echocardiogr; 2010 Jul; 11(6):492-500. PubMed ID: 20551250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doppler tissue imaging: regional myocardial function in hypertrophic cardiomyopathy and in athlete's heart.
    Cardim N; Oliveira AG; Longo S; Ferreira T; Pereira A; Reis RP; Correia JM
    J Am Soc Echocardiogr; 2003 Mar; 16(3):223-32. PubMed ID: 12618730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Early diastolic dysfunction of the left ventricle affected by hypertrophy and abnormal histopathology in hypertrophic cardiomyopathy].
    Sugihara N; Shimizu M; Suematsu T; Horita Y; Shimizu K; Ohsato K; Shibayama S; Nakao T; Kitamura M; Takeda R
    J Cardiol; 1990; 20(1):71-81. PubMed ID: 2151236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.